The hypothesis for a role of viral infections on the pathogenesis of systemic lupus erythematosus has been discussed in many works, particularly that of cytomegalovirus and Epstein Barr virus infections as trigger of autoimmune processes. Here, we describe the case of a young woman affected by systemic lupus erythematosus with marked hepatic involvement presenting IgM antibodies against cytomegalovirus, herpesvirus and herpes zoster virus in the absence of virus. The meaning of these laboratory findings is discussed.
Anti-cytomegalovirus (CMV), anti-Epstein Barr Virus (EBV) and anti-Herpes Zoster Virus (HZV) antibodies have often been found in the serum of patients with Systemic Lupus Erythematosus (SLE) (1-6). These findings led to the hypothesis for a role of viral infections on the pathogenesis of this disease, through a mechanism of immunologic cross reactivity of viral antigens with self-antigens, that could induce the synthesis of antiviral antibodies reacting with autoantigens. Such mechanism has been recognized with proteinic components of EBV and CMV (7) (8) (9) (10) .
Although viral infections were seen as possible causes of inducing the autoimmune process, the altered immune system of such patients could also suggest that infection is an effect rather than a cause of immune over-reaction.
In the present case we report the contemporary presence of anti-CMV, anti-Herpesvirus (HSV) and anti-HZV IgM antibodies in the course of SLE, in the absence of respective viruses.
Case report
A 22 year-old female patient suffering from diffuse arthralgias, asthenia and irregular fever with peaks of 39°C every 4-5 days and periods of apyrexia was hospitalized in May 2007. About 10 months prior the observations, mild leukopenia (WBC== 3200/mm 3 ) , with granulocytopenia, and increased levels of gamma globulins (24%) had been recorded. Historically, no other symptom has been described, except for the occasional appearance of photosensitivity and malar rash in the last months. Clinical examination at hospitalization revealed only a mild malar rash, hepatomegaly, and left laterocervical lymph node enlargement. As presented in Table I , laboratory data revealed high erythrocyte sedimentation rate (ESR) (P h 50mm), increased levels of gamma globulins, anemia, leukopenia, decreased levels of serum complement fractions Chemiluminescence (Kit DiaSorin, Saluggia, Italy) revealed the presence of anti-CMV, anti-HSV and anti-HZV IgM, and absence of anti-EBV IgM, while IgG antibodies for all these viruses were present. A multiplex polymerase chain reaction (PCR) assay (ARROW Diagnostics -denova, Italy), performed on plasma sample to amplify herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus DNA in the serum, revealed absence of CMV, HZV and HSV. Then, the hypothesis of viral infection was dismissed (11), diagnosis of SLE was made and steroid treatment was started (prednisone 50 mg daily). Fever and arthralgias disappeared within 48 hours, and two weeks later a significant decrease of ESR (I" h= 5), and increased levels of serum C3, C4.and WBC were recorded, while thransaminases were nearly normal. This dosage of steroids was administered for a month and then every 20 days reduced by 10 mg/daily, until reaching a maintenance dose of 15 mg/daily.
In the follow-up (the last time was eight months later) clinical conditions improved: fever and arthralgias were absent, hepatomegaly and lymph node enlargement disappeared. During the follow-up hydroxychloroquine was added to the therapy (200 mg orally twice daily) for the treatment of malar rash.
DISCUSSION
Viruses have been speculated as possible causes of the autoimmune process in SLE (12) . In our case, clinical and immunological findings indicated a diagnosis ofSLE and, in this regard, the positivity for anti-CMV, anti-HSV and anti-HZV IgM suggested a Possible trigger role of viral infections in the onset of the disease. However, the eventual presence of viral agents was considered an obstacle to begin steroid treatment, because of the risk of encephalitis, so Multiplex PCR assay was performed to confirm the presence of viral antigen, and the negativity of this test for all these viruses induced a revision of the viral hypothesis: the absence of viral antigen suggested that anti-viral IgM antibodies could be considered not specific. This possibility has been already described in the course of lupus nephritis (13) ; obviously, this does not exclude the pathogenic role of viral agents in the beginning of autoimmune process, suggested by many studies (1-6, 14) . On the basis of our data, the hypothesis of a transient viraemia with maintenance of specific IgM antiviral antibody synthesis cannot be excluded, but this possibility appears unlikely in our case: first of all, the acute hepatic injury, so evident in our patient, is difficult to explain in the absence of viral replication, and then the ready response to the steroid treatment is typical of an autoimmune condition rather than a viral infection. Our patient refused liver biopsy, but it must be remembered that hepatic damage in the course of SLE occurs in about 25% of cases and its histologic features are unfortunately not specific (15) . Concerning the aspecificity ofIgM antibodies, a pre-existing autoimmune condition, without clinical evidence, is reinforced by previous laboratory findings indicating granulocytopenia and immune hyperactivity (increased levels of gamma globulins) ten months before the onset of the symptomatology.
The causes of false positivity in the course of SLE are still unknown, they could be linked to the hyperactivity of B cells, typical of this disease, but until now literature data on this specific point are poor. However, the present study indicates the need to detect, by PCR, the viral replication in all the cases presenting these autoantibodies. There is no agreement among the authors about the possibility of excluding virus infection by PCR, but, at the present time, it is the most widely used method to evidence viral replication. To the best of our knowledge this presentation is the first evidence of non-specific IgM antibodies in course of SLE with prevalent hepatic involvement.
